Replimune

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.

About REPL

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer.

CEO

Sushil Patel

CEOSushil Patel

Employees

479

Employees479

Headquarters

Woburn, Massachusetts

HeadquartersWoburn, Massachusetts

Founded

2015

Founded2015

Employees

479

Employees479

REPL Key Statistics

Market cap

270.07M

Market cap270.07M

Price-Earnings ratio

-1.69

Price-Earnings ratio-1.69

Dividend yield

—

Dividend yield—

Average volume

2.32M

Average volume2.32M

High today

$5.72

High today$5.72

Low today

$3.12

Low today$3.12

Open price

$4.12

Open price$4.12

Volume

27.66M

Volume27.66M

52 Week high

$17.00

52 Week high$17.00

52 Week low

$2.68

52 Week low$2.68

REPL News

TipRanks 10h

Replimune Group Completes FDA Meeting on RP1 Application

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

67%

of 9 ratings

Buy

22.2%

Hold

66.7%

Sell

11.1%

People also own

Based on the portfolios of people who own REPL. This list is generated using Robinhood data, and it’s not a recommendation.